Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
If You Only Own Tech Stocks, Jim Cramer Has a Blunt Warning for You in 2026
05:00pm, Monday, 23'rd Mar 2026
Over the last three years, rising demand for artificial intelligence (AI) has fueled market-beating gains in technology stocks. Current market conditions are making it clear that investors can no long
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Monday, 23'rd Mar 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Distinguished physician with a career spanning over 29 years in drug development and medical affairs highlighted by blockbuster successes in hematology and oncology Coordinated and achieved more than
Magnus Financial Group LLC Sells 2,124 Shares of Johnson & Johnson $JNJ
07:32am, Monday, 23'rd Mar 2026
Magnus Financial Group LLC trimmed its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 9.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the
MassMutual Private Wealth & Trust FSB Has $40.54 Million Stock Holdings in Johnson & Johnson $JNJ
06:52am, Monday, 23'rd Mar 2026
MassMutual Private Wealth and Trust FSB trimmed its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 3.0% during the undefined quarter, according to its most recent disclosure with the Securit
Johnson & Johnson $JNJ Shares Purchased by St. Louis Financial Planners Asset Management LLC
06:17am, Monday, 23'rd Mar 2026
St. Louis Financial Planners Asset Management LLC lifted its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 35.3% during the fourth quarter, according to the company in its most recent Form
Johnson & Johnson $JNJ Stock Position Lifted by Neville Rodie & Shaw Inc.
05:34am, Sunday, 22'nd Mar 2026
Neville Rodie and Shaw Inc. raised its holdings in Johnson and Johnson (NYSE: JNJ) by 2.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (S
QP Wealth Management LLC Purchases Shares of 2,258 Johnson & Johnson $JNJ
05:34am, Sunday, 22'nd Mar 2026
QP Wealth Management LLC acquired a new position in Johnson and Johnson (NYSE: JNJ) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,258 shar
Armstrong Henry H Associates Inc. Has $66.39 Million Holdings in Johnson & Johnson $JNJ
04:56am, Sunday, 22'nd Mar 2026
Armstrong Henry H Associates Inc. lessened its holdings in Johnson and Johnson (NYSE: JNJ) by 2.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor o
City Center Advisors LLC Makes New $462,000 Investment in Johnson & Johnson $JNJ
07:00am, Saturday, 21'st Mar 2026
City Center Advisors LLC purchased a new position in Johnson and Johnson (NYSE: JNJ) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The
Best Dividend Aristocrats As Of March 20, 2026
02:12am, Saturday, 21'st Mar 2026
Dividend Aristocrats, tracked via NOBL, outperformed SPY YTD despite a sharp March pullback, with 44 Aristocrats beating SPY and 17 posting double-digit gains. Momentum, valuation (via dividend yield
CTC Alternative Strategies Ltd. Has $22.46 Million Position in Johnson & Johnson $JNJ
04:34am, Friday, 20'th Mar 2026
CTC Alternative Strategies Ltd. raised its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 3,139.3% during the third quarter, according to its most recent disclosure with the Securities and E
How Much Do you Need To Invest to Make $100k On Dividends Right Now?
02:57pm, Thursday, 19'th Mar 2026
Let's cut through the noise on this dividend dream that keeps investors up at night. The key question many investors have is how much cash do you need parked in a portfolio to crank out $100,000 in an
J&J Expands New Drug Portfolio With Icotyde's FDA Approval
01:15pm, Thursday, 19'th Mar 2026
J&J wins FDA nod for Icotyde, a once-daily oral psoriasis pill, boosting its new drugs portfolio and challenging injectable treatments in a key market.
The Big 3: ORCL, JNJ, SBUX
01:00pm, Thursday, 19'th Mar 2026
Dan Deming urges investors to stay nimble as markets grapple with crude oil, gold, and silver volatility. That said, he sees trading opportunities available in the markets.
